Release Date: 11/08/14 17:20 Summary: Resignation of Director and Appendix 3Z Price Sensitive: No Download Document 400.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%